NCT06260345 CommunautAry Pediatric bacteRial Infection in Intensive CarE Unit
| NCT ID | NCT06260345 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Association Clinique Thérapeutique Infantile du val de Marne |
| Condition | Hospitalized Children |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2024-01-01 |
| Primary Completion | 2030-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 2024-01-01 with a primary completion date of 2030-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Severe bacterial infections are a worldwide scourge. However, the epidemiology of this type of infection varies over time. It is therefore essential to monitor them in order to prevent them more effectively. At this time, in France, no monitoring exists for this kind of infections.
Eligibility Criteria
Inclusion Criteria: * Age \<18 years (only hospitalized children) * Severe communautary bacterial infection defined by hospitalization in a pediatric intensive care unit (documentation of infection by identification of the bacteria in a sterile environment). Exclusion Criteria: * Refusal by one of the parents or by Child in understanding age * Nosocomial infection
Contact & Investigator
Michael Levy
PRINCIPAL INVESTIGATOR
CHU Robert Debré, Paris
Frequently Asked Questions
Who can join the NCT06260345 clinical trial?
This trial is open to participants of all sexes, up to 18 Years, studying Hospitalized Children. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06260345 currently recruiting?
Yes, NCT06260345 is actively recruiting participants. Contact the research team at corinne.levy@activ-france.fr for enrollment information.
Where is the NCT06260345 trial being conducted?
This trial is being conducted at Créteil, France.
Who is sponsoring the NCT06260345 clinical trial?
NCT06260345 is sponsored by Association Clinique Thérapeutique Infantile du val de Marne. The principal investigator is Michael Levy at CHU Robert Debré, Paris. The trial plans to enroll 3,000 participants.